Medigen Biotechnology Corp.

TPEX:3176 Stock Report

Market Cap: NT$5.4b

Medigen Biotechnology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Shun-Lang Chang

Chief executive officer

NT$9.8m

Total compensation

CEO salary percentage33.4%
CEO tenure7.8yrs
CEO ownershipn/a
Management average tenure3.3yrs
Board average tenure20.8yrs

Recent management updates

Recent updates

Is Medigen Biotechnology (GTSM:3176) Using Debt Sensibly?

Apr 13
Is Medigen Biotechnology (GTSM:3176) Using Debt Sensibly?

Medigen Biotechnology (GTSM:3176) Shareholders Have Enjoyed A 83% Share Price Gain

Feb 19
Medigen Biotechnology (GTSM:3176) Shareholders Have Enjoyed A 83% Share Price Gain

Does Medigen Biotechnology (GTSM:3176) Have A Healthy Balance Sheet?

Dec 29
Does Medigen Biotechnology (GTSM:3176) Have A Healthy Balance Sheet?

CEO Compensation Analysis

How has Shun-Lang Chang's remuneration changed compared to Medigen Biotechnology's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-NT$561m

Sep 30 2023n/an/a

-NT$594m

Jun 30 2023n/an/a

-NT$663m

Mar 31 2023n/an/a

-NT$689m

Dec 31 2022NT$10mNT$3m

-NT$676m

Compensation vs Market: Shun-Lang's total compensation ($USD300.94K) is above average for companies of similar size in the TW market ($USD172.48K).

Compensation vs Earnings: Insufficient data to compare Shun-Lang's compensation with company performance.


CEO

Shun-Lang Chang

7.8yrs

Tenure

NT$9,810,000

Compensation

Mr. Shun-Lang Chang is General Manager of Medigen Biotechnology Corp. since July 01, 2016. He serves as Director at Cellxpert Biotechnology Co., Ltd. and Director at Medigen Biotechnology Corp. (Beijing)....


Leadership Team

NamePositionTenureCompensationOwnership
Shun-Lang Chang
General Manager7.8yrsNT$9.81mno data
Ya-Ling Chiang
Assistant Vice President of Operations & Management Department4.8yrsNT$3.04mno data
Chin-Yen Chen
Assistant Vice President of Drug Development Departmentno dataNT$2.54mno data
Feng-Hua Chen
Finance Manager3.3yrsno datano data
I-Ju Chen
Accounting Manager3.3yrsno datano data
Chieh-Liang Lin
Chief Scientific Officerless than a yearno datano data

3.3yrs

Average Tenure

Experienced Management: 3176's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Shi-Chung Chang
Chairman20.8yrsno datano data
Por-Hsiung Lai
Independent Director8.8yrsNT$298.00kno data
Tse Ling Chang
Representative Director23.7yrsNT$132.00kno data
Min-Li Chuang
Representative Director22.7yrsNT$138.00kno data
Shang Cai
Supervisorno datano datano data
Dun Hong
Supervisorno datano datano data
Jing Wu
Supervisorno datano datano data
Tzu-Liang Huang
Representative Director22.7yrsNT$138.00kno data
Shui-Ming Chuang
Independent Director5.8yrsNT$298.00kno data
Pei-Wei Chen
Independent Director2.7yrsNT$298.00kno data

20.8yrs

Average Tenure

Experienced Board: 3176's board of directors are seasoned and experienced ( 20.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.